𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma

✍ Scribed by U. Kaiser; M. Oldenburg; G. Jaques; B. Auerbach; K. Havemann

Book ID
105990177
Publisher
Springer
Year
1996
Tongue
English
Weight
179 KB
Volume
73
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A review of the cytokine network in mult
A review of the cytokine network in multiple myeloma : Diagnostic, prognostic, and therapeutic implications
✍ Vito Michele Lauta 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

## Abstract Because many studies have focused on growth factors in multiple myeloma, the study of the cytokine network appears to be useful for this purpose. Interleukin‐6 (IL‐6) and IL‐2 with their soluble receptors (IL‐3, IL‐4, IL‐10, and IL‐11) have been examined. Plasma cells may produce IL‐6 b

TGFβR2 aberrant methylation is a potenti
TGFβR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma
✍ Fabrício de Carvalho; Gisele W. B. Colleoni; Manuella S. Sampaio Almeida; André 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB

## Abstract Multiple myeloma (MM) is an incurable hematological malignancy. Different studies demonstrated the occurrence of genetic and epigenetic alterations in MM. The aberrant methylation is one of the most frequent epigenetic alterations in human genome. This study evaluated the aberrant methy